Drugs used as radiosensitizers: clinical and pharmaceutical aspects and prospects (literature review)
Authors: Andrushchenko I.V. Afanasieva I.O. Дата: 2025-06-30
Clinical Case of Laparoscopic Simultaneous Resection of the Dorsoventral Segment of the Liver and Transverse Colon Resection
Authors: Burlaka A. Skyba V. Zemskov S. Mykytyuk A.... Дата: 2025-06-27
Possibilities of modern visualization methods in planning radiation therapy in patients with cervical cancer
Authors: Ivankova V.S. Domina E.A. Khrulenko T.V. Baranovska L.M.... Дата: 2025-06-27
Management strategy for gastrointestinal stromal tumors (GIST): current status and future perspectives
Authors: Kondratskyi Yu.M. Koval N.O. Kolesnyk A.V. Kozak E.O.... Дата: 2025-06-27
Prognostic factors for successful discontinuation of tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia
Authors: Tomashevska N.Y. Kotlyarchuk K.B. Korolchuk O.S. Boyko O.I.... Дата: 2025-06-27
Modern approaches to the treatment of advanced ovarian cancer in the 1st line therapy (PAOLA-1 study) and recurrent ovarian cancer regardless of the presence of BRCA mutations, as well as modern cytoreductive approaches (based on materials from the ESGO 2025 Congress)
Дата: 2025-06-25
Peritoneal carcinomatosis from gastric cancer treatment perspectives. A narrative review
Authors: Pepenin M.O. Kondratskyi Y.M. Dobrzhanskyi O.Y. Kolesnyk A.V.... Дата: 2025-06-19
Retrospective analysis of radical treatment of patients with stage III–IV larynpharyngetal cancer
Authors: Mykhailiuk P.I. Hirna H.A. Kostyshyn I.D. Tsybran S.S.... Дата: 2025-06-12
Subscapular artery system flaps in head and neck reconstructive surgery: literature review and clinical experience
Authors: Fokin H.H. Kravets O.V. Т. 15, №1 (57)
Urachal carcinoma in the practice of a surgical oncologist: a clinical case series
Authors: Antoniv R.R. Pysar A.M. Т. 15, №1 (57)
Side effects of iodine-negative thyroid cancer targeted therapy
Authors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57)
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: a matching-adjusted indirect comparison
Т. 15, №1 (57)
Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score <1%: pooled analysis of outcomes after five years of follow-up
Т. 15, №1 (57)
Thromboprophylaxis with original enoxaparin in oncology patients
Т. 15, №1 (57)
Inferior vena cava resection and reconstruction with falciform ligament graft for leiomyosarcoma. Case report
Authors: Kvasivka O.O. Moiseienko A.B. Pareniuk R.Y. Pepenin I.O.... Т. 15, №1 (57)

12345...1020...Последняя »